208 related articles for article (PubMed ID: 27377869)
1. MicroRNA-26a-interleukin (IL)-6-IL-17 axis regulates the development of non-alcoholic fatty liver disease in a murine model.
He Q; Li F; Li J; Li R; Zhan G; Li G; Du W; Tan H
Clin Exp Immunol; 2017 Jan; 187(1):174-184. PubMed ID: 27377869
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA 26a prolongs skin allograft survival and promotes regulatory T cell expansion in mice.
Xie F; Chai J; Zhang Z; Hu Q; Ma T
Transpl Int; 2015 Oct; 28(10):1143-51. PubMed ID: 25865461
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease.
Xu M; Zheng XM; Jiang F; Qiu WQ
J Cell Biochem; 2018 Jul; 119(7):5864-5874. PubMed ID: 29575055
[TBL] [Abstract][Full Text] [Related]
4. miR-26a Potentially Contributes to the Regulation of Fatty Acid and Sterol Metabolism In Vitro Human HepG2 Cell Model of Nonalcoholic Fatty Liver Disease.
Ali O; Darwish HA; Eldeib KM; Abdel Azim SA
Oxid Med Cell Longev; 2018; 2018():8515343. PubMed ID: 30402207
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-26a Promotes Regulatory T cells and Suppresses Autoimmune Diabetes in Mice.
Ma H; Zhang S; Shi D; Mao Y; Cui J
Inflammation; 2016 Feb; 39(1):1-9. PubMed ID: 26208605
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.
Fu X; Dong B; Tian Y; Lefebvre P; Meng Z; Wang X; Pattou F; Han W; Wang X; Lou F; Jove R; Staels B; Moore DD; Huang W
J Clin Invest; 2015 Jun; 125(6):2497-509. PubMed ID: 25961460
[TBL] [Abstract][Full Text] [Related]
7. An Endoplasmic Reticulum Stress-MicroRNA-26a Feedback Circuit in NAFLD.
Xu H; Tian Y; Tang D; Zou S; Liu G; Song J; Zhang G; Du X; Huang W; He B; Lin W; Jin L; Huang W; Yang J; Fu X
Hepatology; 2021 Apr; 73(4):1327-1345. PubMed ID: 32567701
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease.
Lei L; Zhou C; Yang X; Li L
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):819-831. PubMed ID: 29569260
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.
Wang XC; Zhan XR; Li XY; Yu JJ; Liu XM
World J Gastroenterol; 2014 Dec; 20(47):17914-23. PubMed ID: 25548489
[TBL] [Abstract][Full Text] [Related]
12. Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles.
Zhang YJ; Hu Y; Li J; Chi YJ; Jiang WW; Zhang F; Liu YL
Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):65-79. PubMed ID: 28119261
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
Yang X; Liang L; Zhang XF; Jia HL; Qin Y; Zhu XC; Gao XM; Qiao P; Zheng Y; Sheng YY; Wei JW; Zhou HJ; Ren N; Ye QH; Dong QZ; Qin LX
Hepatology; 2013 Jul; 58(1):158-70. PubMed ID: 23389848
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA 26a modulates regulatory T cells expansion and attenuates renal ischemia-reperfusion injury.
Liang S; Wang W; Gou X
Mol Immunol; 2015 Jun; 65(2):321-7. PubMed ID: 25728641
[TBL] [Abstract][Full Text] [Related]
15. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
Zhuge B; Li G
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
[TBL] [Abstract][Full Text] [Related]
16. miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.
Xiao J; Bei Y; Liu J; Dimitrova-Shumkovska J; Kuang D; Zhou Q; Li J; Yang Y; Xiang Y; Wang F; Yang C; Yang W
J Cell Mol Med; 2016 Feb; 20(2):204-16. PubMed ID: 26648452
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis.
Giles DA; Moreno-Fernandez ME; Stankiewicz TE; Cappelletti M; Huppert SS; Iwakura Y; Dong C; Shanmukhappa SK; Divanovic S
PLoS One; 2016; 11(2):e0149783. PubMed ID: 26895034
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-26a-CD36 signaling pathway: Pivotal role in lipid accumulation in hepatocytes induced by PM
Ding D; Ye G; Lin Y; Lu Y; Zhang H; Zhang X; Hong Z; Huang Q; Chi Y; Chen J; Dong S
Environ Pollut; 2019 May; 248():269-278. PubMed ID: 30798028
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice.
Zhang ZC; Liu Y; Xiao LL; Li SF; Jiang JH; Zhao Y; Qian SW; Tang QQ; Li X
J Hepatol; 2015 Dec; 63(6):1466-75. PubMed ID: 26272872
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47
Li M; He Y; Zhou Z; Ramirez T; Gao Y; Gao Y; Ross RA; Cao H; Cai Y; Xu M; Feng D; Zhang P; Liangpunsakul S; Gao B
Gut; 2017 Apr; 66(4):705-715. PubMed ID: 27679493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
